5-Fluorouracil treatment induces characteristic T>G mutations in human cancer
5-Fluorouracil (5-FU) is a commonly used chemo drug to treat cancer patients. Using in vitro 5-FU treated organoids and in vivo 5-FU treated human cancer data, the authors describe a 5-FU mutational signature that is similar to COSMIC signature 17 frequently observed in untreated cancers
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/367df1c239a3400ab814acaa85f4ccbc |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:367df1c239a3400ab814acaa85f4ccbc |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:367df1c239a3400ab814acaa85f4ccbc2021-12-02T15:35:57Z5-Fluorouracil treatment induces characteristic T>G mutations in human cancer10.1038/s41467-019-12594-82041-1723https://doaj.org/article/367df1c239a3400ab814acaa85f4ccbc2019-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-12594-8https://doaj.org/toc/2041-17235-Fluorouracil (5-FU) is a commonly used chemo drug to treat cancer patients. Using in vitro 5-FU treated organoids and in vivo 5-FU treated human cancer data, the authors describe a 5-FU mutational signature that is similar to COSMIC signature 17 frequently observed in untreated cancersSharon ChristensenBastiaan Van der RoestNicolle BesselinkRoel JanssenSander BoymansJohn W. M. MartensMarie-Laure YaspoPeter PriestleyEwart KuijkEdwin CuppenArne Van HoeckNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-11 (2019) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Science Q |
| spellingShingle |
Science Q Sharon Christensen Bastiaan Van der Roest Nicolle Besselink Roel Janssen Sander Boymans John W. M. Martens Marie-Laure Yaspo Peter Priestley Ewart Kuijk Edwin Cuppen Arne Van Hoeck 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer |
| description |
5-Fluorouracil (5-FU) is a commonly used chemo drug to treat cancer patients. Using in vitro 5-FU treated organoids and in vivo 5-FU treated human cancer data, the authors describe a 5-FU mutational signature that is similar to COSMIC signature 17 frequently observed in untreated cancers |
| format |
article |
| author |
Sharon Christensen Bastiaan Van der Roest Nicolle Besselink Roel Janssen Sander Boymans John W. M. Martens Marie-Laure Yaspo Peter Priestley Ewart Kuijk Edwin Cuppen Arne Van Hoeck |
| author_facet |
Sharon Christensen Bastiaan Van der Roest Nicolle Besselink Roel Janssen Sander Boymans John W. M. Martens Marie-Laure Yaspo Peter Priestley Ewart Kuijk Edwin Cuppen Arne Van Hoeck |
| author_sort |
Sharon Christensen |
| title |
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer |
| title_short |
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer |
| title_full |
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer |
| title_fullStr |
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer |
| title_full_unstemmed |
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer |
| title_sort |
5-fluorouracil treatment induces characteristic t>g mutations in human cancer |
| publisher |
Nature Portfolio |
| publishDate |
2019 |
| url |
https://doaj.org/article/367df1c239a3400ab814acaa85f4ccbc |
| work_keys_str_mv |
AT sharonchristensen 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT bastiaanvanderroest 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT nicollebesselink 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT roeljanssen 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT sanderboymans 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT johnwmmartens 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT marielaureyaspo 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT peterpriestley 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT ewartkuijk 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT edwincuppen 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer AT arnevanhoeck 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer |
| _version_ |
1718386404225974272 |